PepsiCo's Q2 earnings and a 7% post-earnings surge signal the potential beginning of a turnaround, validating my contrarian bullish stance on consumer staples. Strong pricing power, moderating volume ...
Zacks Investment Research on MSN
Wall Street analysts see an 113.73% upside in Compass Therapeutics, Inc. (CMPX): Can the stock really move this high?
Compass Therapeutics, Inc. (CMPX) closed the last trading session at $6.19, gaining 20.2% over the past four weeks, but there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results